Abstract 1577: Levels of Fibroblast Growth Factor 21 (FGF21) in serum as diagnostic biomarker in patients with breast cancer

@article{Knott2015Abstract1L,
  title={Abstract 1577: Levels of Fibroblast Growth Factor 21 (FGF21) in serum as diagnostic biomarker in patients with breast cancer},
  author={M. E. Knott and S. Ranuncolo and M. N{\'u}{\~n}ez and E. Armanasco and L. Puricelli and M. Lorenzo},
  journal={Cancer Research},
  year={2015},
  volume={75},
  pages={1577-1577}
}
Epidemiological studies have suggested a close link between obesity and breast cancer. There is an immediate need to investigate the potential pathways linking obesity and breast cancer to have an early diagnosis in patients and optimize the chance of cure. FGF21 is a regulator of local and systemic metabolic homeostasis and its expression is induced in response to diverse physiological or pathological stressors. High serum levels of FGF21 were found in obese individuals, subjects with… Expand